Antihypertensive efficacy of amlodipine and losartan after two 'missed' doses in patients with mild to moderate essential hypertension
dc.contributor.author | Ribeiro, Artur Beltrame [UNIFESP] | |
dc.contributor.author | Mion Junior, Decio | |
dc.contributor.author | Marin, M. J. | |
dc.contributor.author | Majul, Claudio | |
dc.contributor.author | Botero, R. | |
dc.contributor.author | Lopez, N. R. | |
dc.contributor.author | Gonzalez, S. | |
dc.contributor.author | Izurieta, H. | |
dc.contributor.author | Francischetti, Emilio Antonio | |
dc.contributor.author | Latin Amer Hypertension Study Grp | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Policlin Bancario | |
dc.contributor.institution | Hosp Santojanni | |
dc.contributor.institution | Clin Medellin | |
dc.contributor.institution | Ctr Med Docente La Trinidad | |
dc.contributor.institution | Gen Hosp Durango | |
dc.contributor.institution | Ctr Med Alemania | |
dc.contributor.institution | Rio de Janeiro Sch Med | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.date.accessioned | 2018-06-15T18:02:33Z | |
dc.date.available | 2018-06-15T18:02:33Z | |
dc.date.issued | 2007-11-01 | |
dc.description.abstract | We compared the effects of amlodipine (5 - 10 mg, n = 94) and losartan (50 100 mg, n = 94) on the lowering of blood pressure (BP) at steady state and after two missed doses, as well as on tolerability. This was a randomized, double-blind study of 12 weeks of active treatment followed by 2 days of placebo treatment. Twenty-four-hour ambulatory blood pressure monitoring and office BP measurements were performed at baseline, week 12 and after the 2-day drug holiday. After 12 weeks, amlodipine was significantly more effective than losartan in reducing both 24-h systolic blood pressure (SBP) (-18.0 versus -10.8 mmHg) and diastolic blood pressure (DBP) (-10.6 versus -8.0 mmHg). While mean SBP and DBP for both treatments increased comparably during the drug holiday, BP values remained significantly lower than baseline for both treatments. The superior BP-lowering effect of amlodipine compared with losartan was maintained during the drug holiday. | en |
dc.description.affiliation | Hosp Rim & Hipertensao, Escola Paulista Med, Sao Paulo, Brazil | |
dc.description.affiliation | Policlin Bancario, Div Cardiol, Ctr Hipertens Arterial, Ciudad de Buenos Aires, Argentina | |
dc.description.affiliation | Hosp Santojanni, Serv Cardiol, Ciudad de Buenos Aires, Argentina | |
dc.description.affiliation | Clin Medellin, Medellin, Colombia | |
dc.description.affiliation | Ctr Med Docente La Trinidad, Caracas, Venezuela | |
dc.description.affiliation | Gen Hosp Durango, Durango, Mexico | |
dc.description.affiliation | Ctr Med Alemania, Quito, Ecuador | |
dc.description.affiliation | Rio de Janeiro Sch Med, Rio De Janeiro, Brazil | |
dc.description.affiliation | Univ Sao Paulo, Sch Med, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Hosp Rim & Hipertensao, Escola Paulista Med, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 762-772 | |
dc.identifier | https://dx.doi.org/10.1177/147323000703500604 | |
dc.identifier.citation | Journal Of International Medical Research. Worthing: Field House Publishing Llp, v. 35, n. 6, p. 762-772, 2007. | |
dc.identifier.doi | 10.1177/147323000703500604 | |
dc.identifier.issn | 0300-0605 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/44438 | |
dc.identifier.wos | WOS:000251382700004 | |
dc.language.iso | eng | |
dc.publisher | Field House Publishing Llp | |
dc.relation.ispartof | Journal Of International Medical Research | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Amlodipine | en |
dc.subject | Losartan | en |
dc.subject | Antihypertensive drugs | en |
dc.subject | Hypertension | en |
dc.subject | Ambulatory blood pressure monitoring | en |
dc.subject | Drug holiday | en |
dc.subject | Therapeutic coverage | en |
dc.title | Antihypertensive efficacy of amlodipine and losartan after two 'missed' doses in patients with mild to moderate essential hypertension | en |
dc.type | info:eu-repo/semantics/article |